The C5a receptor inhibitor avacopan is being studied for the treatment of antineu- trophil cytoplasmic antibody (ANCA)–associated vasculitis.
Kategorien
ANCA Vaskulitis
The C5a receptor inhibitor avacopan is being studied for the treatment of antineu- trophil cytoplasmic antibody (ANCA)–associated vasculitis.